1.32
1.92%Today
Market Cap
80.26M
Volume
125.33K
52W High
3.60
52W Low
0.85
No historical price data available
No price history data available for the selected time period.
Try selecting a different time range.
Company Overview
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.
Company Information
- CEO
- Daniel J. O'Connell
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 61
Contact Information
- Website
- https://acumenpharm.com
- Address
- 427 Park Street
- Country
- US